Skip to main content
Equibles

Mohit Bansal

Analyst

Wells Fargo

Equibles does not estimate personal net worth.

About Mohit Bansal

Mohit Bansal is recorded as Analyst at Wells Fargo. Mohit Bansal has spoken on 40 earnings calls and 11 other investor events across 20 companies, most recently for Vera Therapeutics, Inc. on October 22, 2026. Those appearances were for AbbVie Inc. (ABBV), Halozyme Therapeutics, Inc. (HALO), ELI LILLY & Co (LLY), Gilead Sciences, Inc. (GILD), Biomarin Pharmaceutical Inc (BMRN) and 15 other companies. The companies whose calls Mohit Bansal spoke on are classified in the Healthcare sector.

Mohit Bansal on recent calls

“So just wanted to understand, Dr. Barrett, so trying to tie your two comments here.”
Analyst — Wells Fargo, Virtual Investor Event: ASN Kidney Week 2026 ·
“I'm one of the biotech and pharma analysts here at Wells Fargo. And I have a pleasure to introduce Amgen management team with us today. So we have Thomas Dittridge, Chief Financial Officer of the company.”
Analyst — Wells Fargo, Wells Fargo 21st Annual Healthcare Conference ·
“I'm one of the biotech and pharma at Wells Fargo, and I have the Vertex IR team with us, Suzy Lisa, Hedayar, and Manisha Pai. She's part of the IR team as well, so thank you very much both of us, both of you, to join us.”
Analyst — Wells Fargo, 2026 Wells Fargo 21st Annual Healthcare Conference ·
“So you have done an amazing job in last one year doing all those deals and building the platform. Can you talk a little bit about the journeys with these deals and all and how do you see the future of Halozyme beyond the enhanced platform at this point?”
Analyst — Wells Fargo, Wells Fargo 21st Annual Healthcare Conference ·
“I'm one of the biotech and pharma analysts here at Wells Fargo, and I'm joined by team Biomarine with us today. So we have Greg Freitberg with us, the head of R&D at Biomarine, and then Kristin Hubbard.”
Analyst — Wells Fargo, Wells Fargo 21st Annual Healthcare Conference ·

Affiliation history

  • Wells Fargo

    Analyst

    Source not stated

    Current

Company network

AMGEN-T

1 appearance Latest appearance 2026-09-10

Recent activity

Show 39 earlier activities